Janaina Macedo-Da-Silva

Janaina Macedo-Da-Silva

Auto-generated profile, based on publicly available information

Janaina Macedo-Da-Silva

Instituto de Biosciências, Universidade de São Paulo, Brasil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Molecular Immunology
Verified
Journal Article
Closed access
JMJanaina Macedo-Da-Silva
Janaina Macedo-Da-Silva
VSVeronica Feijoli Santiago
Veronica Feijoli Santiago
LRLivia Rosa-Fernandes
Livia Rosa-Fernandes
Claudio Romero Farias MarinhoClaudio Romero Farias Marinho
Claudio Romero Farias Marinho
Giuseppe PalmisanoGiuseppe Palmisano
Giuseppe Palmisano

1 January 2023 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
LALuz Andreone
Luz Andreone
ASAncely dos Santos
Ancely dos Santos
RMRosangela A Wailemann Mansano
Rosangela A Wailemann Mansano
LTL.F. Terra
L.F. Terra
VGVinicius de Morais Gomes
Vinicius de Morais Gomes
MPM.J. Perone
M.J. Perone
Islet transplantation represents a therapeutic option for type 1 diabetes (T1D). Long-term viability of transplanted islets requires improvement. Mesenchymal stromal cells (MSCs) have been proposed as adjuvants for islet transplantation facilitating grafting and functionality. Stem cell aggregation provides physiological interactions between cells and enhances the in situ concentration of modulators of inflammation and immunity. We established a hanging-drop culture of adult human skin fibroblast-like cells as spheroids, and skin spheroid-derived cells (SphCs) were characterized. We assessed the potential of SphCs in improving islet functionality by cotransplantation with a marginal mass of allogeneic islets in an experimental diabetic mouse model and characterized the secretome of SphCs by mass spectrometry-based proteomics. SphCs were characterized as multipotent progenitors and their coculture with anti-CD3 stimulated mouse splenocytes decreased CD4+ T cell proliferation with skewed cytokine secretion through an increase in the Th2/Th1 ratio profile. SphCs-conditioned media attenuated apoptosis of islets induced by cytokine challenge in vitro and importantly, intratesticular SphCs administration did not show tumorigenicity in immune-deficient mice. Moreover, SphCs improved glycemic control when cotransplanted with a marginal mass of allogeneic islets in a diabetic mouse model without pharmacological immunosuppression. SphCs' protein secretome differed from its paired skin fibroblast-like counterpart in containing 70% of up- and downregulated proteins and biological processes that overall positively influenced islets such as cytoprotection, cellular stress, metabolism, and survival. In summary, SphCs improved the performance of transplanted allogeneic islets in an experimental T1D model, without pharmacological immunosuppression. Future research is warranted to identify SphCs-secreted factors responsible for islets' endurance.